# Haisco-USA Pharmaceuticals, Inc. – FDA Inspection, Oct 9, 2025

Source: https://www.keypedia.com/records/fda_inspections/haisco-usa-pharmaceuticals-inc/7d806d12-5fe0-4d76-b04c-cb93c1646073
Source feed: FDA_Inspections

> FDA inspection 1286348 of Haisco-USA Pharmaceuticals, Inc., October 09, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286348
- Company Name: Haisco-USA Pharmaceuticals, Inc.
- Inspection Date: 2025-10-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)

Company: https://www.keypedia.com/companies/haisco-usa-pharmaceuticals-inc/841bf104-d213-438a-8459-628b7a236b1a

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
